Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells

Abstract

These data serve as proof of principle that Kv1.3 inhibitors kills GBM cells, but drugs that act in vivo against glioblastoma must be developed to translate these findings in vivo.